| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2570292 | Toxicology and Applied Pharmacology | 2009 | 7 Pages |
Abstract
The Fhit tumor suppressor protein possesses Ap3A (diadenosine triphosphate — ApppA) hydrolytic activity in vitro and its gene is found inactive in many pre-malignant states due to gene inactivation. For several years Fhit has been a widely investigated protein as its cellular function still remains largely unsolved. Fhit was shown to act as a molecular ‘switch’ of cell death via cascade operating on the influence of ATR–Chk1 pathway but also through the mitochondrial apoptotic pathway. Notably, Fhit was reported by our group to enhance the overall eradication effect of porphyrin-mediated photodynamic treatment (PDT). In this review the up-to-date findings on Fhit protein as a tumor suppressor and its role in PDT are presented.
Related Topics
Life Sciences
Environmental Science
Health, Toxicology and Mutagenesis
Authors
Joanna Zawacka-Pankau,